Why the study?
Obstacles in heart failure clinical research motivated the Heart Failure Collaboratory to improve clinical research infrastructure and promote the development of novel therapies.
Key points are not available for this paper at this time.
Design
Review
Highlights HF Collaboratory initiatives to improve trial infrastructure; leaves open their impact on diversity and efficiency.
The Heart Failure Collaboratory (HFC) is a consortium of stakeholders in the heart failure (HF) community that aims to improve the infrastructure of clinical research to promote development of novel therapies for patients. Since its launch in 2018, HFC has implemented several solutions to tackle obstacles in HF clinical research including training programs to increase the number of clinicians skilled in conducting clinical trials, novel study designs, and advocacy for a diverse and inclusive HF research ecosystem. We highlight some of the HFC successes since its establishment.
No takes yet. Share an insight, caveat, or question.
Alkalbani et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: